Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with I

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
137 Q3 2021 ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER TOPICAL SPONGE 5.40 %w/w Correction
3891 Q3 2021 INK BLACK SW-9008 ORAL CAPSULE, EXTENDED RELEASE 0.28 mg MDE Replacement
3891 Q4 2021 INK BLACK SW-9008 ORAL CAPSULE, EXTENDED RELEASE 0.675 mg MDE Replacement
3941 Q3 2021 ISOMALT SUBLINGUAL POWDER 176.80 mg MDE Replacement
3941 Q4 2021 ISOMALT SUBLINGUAL POWDER 530.4 mg MDE Replacement
3972 Q3 2021 ISOPROPYL PALMITATE TOPICAL CREAM 5.00 %w/w MDE Replacement
3972 Q4 2021 ISOPROPYL PALMITATE TOPICAL CREAM 32.15 mg MDE Replacement
3942 Q4 2021 ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER ORAL TABLET, FILM COATED 53.00 mg Deletion

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English